Skip to main content

Quinaretic News

FDA Medwatch Alert: Aurobindo Pharma USA, Inc. Initiates Recall of Two Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity

October 24, 2022 – East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 1...

FDA Medwatch Alert: Pfizer Voluntary Nationwide Recall of Lots of Accuretic, Quinapril and Hydrochlorothiazide, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-NitrosoQuinapril Content

NEW YORK, NY., March 21,2022. Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

High Blood Pressure, Hypertension

Quinaretic patient information at Drugs.com